المؤلفون: Leng X; Department of Rheumatology and Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing, China., Leszczyński P; Department of Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland., Jeka S; Department of Rheumatology and Connective Tissue Diseases, University Hospital No 2, CM UMK, Bydgoszcz, Poland., Liu S; First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Liu H; Qilu Hospital of Shandong University, Jinan, China., Miakisz M; Twoja Przychodnia Centrum Medyczne, Nowa Sól, Poland., Gu J; The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Kilasonia L; Tbilisi Heart and Vascular Clinic Ltd, Tbilisi, Georgia., Stanislavchuk M; National Pirogov Memorial Medical University, Vinnytsia, Ukraine., Yang X; Bio-Thera Solutions Ltd, Guangzhou, China., Zhou Y; Bio-Thera Solutions Ltd, Guangzhou, China., Dong Q; Bio-Thera Solutions Ltd, Guangzhou, China., Mitroiu M; Biogen International GmbH, Baar, Switzerland., Addison J; Biogen Idec Ltd, Maidenhead, UK., Rezk MF; Biogen International GmbH, Baar, Switzerland., Zeng X; Department of Rheumatology and Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing, China. zengxfpumc@163.com.

المصدر: Arthritis research & therapy [Arthritis Res Ther] 2024 Sep 07; Vol. 26 (1), pp. 157. Date of Electronic Publication: 2024 Sep 07.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Methotrexate*/therapeutic use , Methotrexate*/pharmacokinetics , Methotrexate*/administration & dosage , Biosimilar Pharmaceuticals*/pharmacokinetics , Biosimilar Pharmaceuticals*/therapeutic use , Biosimilar Pharmaceuticals*/administration & dosage , Biosimilar Pharmaceuticals*/adverse effects , Antirheumatic Agents*/pharmacokinetics , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/administration & dosage , Antibodies, Monoclonal, Humanized*/pharmacokinetics , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects, Humans ; Male ; Female ; Double-Blind Method ; Middle Aged ; Adult ; Treatment Outcome ; Aged ; Severity of Illness Index

المؤلفون: Christofides EA; Endocrinology Research Associates, Columbus. Electronic address: christofides@endocrinology-associates.com., Stankiewicz A; NZOZ Medyczne Centrum Diabetologiczno-Endokrynologiczno-Metaboliczne 'Diab-Endo-Met', Kraków, Poland., Denham D; Clinical Trials of Texas, San Antonio., Bellido D; Complejo Hospitalario Universitario de Ferrol, Servicio Endocrinología y Nutricion, Ferrol, Spain., Franek E; Centralny Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji w Warszawie, Centrum Diabetologiczne, Klinika Endokrynologii i Diabetologii, Warszawa, Poland., Nakhle S; Palm Research Center, Las Vegas., Łukaszewicz M; Centrum Badań Klinicznych PI-House, Gdańsk, Poland., Reed J; Endocrine Research Solutions, Roswell., Cózar-León V; Hospital Universitario Nuestra Señora de Valme, Universidad de Sevilla, Servicio de Endocrinología y Nutrición, Sevilla, Spain., Kosch C; Diabetologische Schwerpunktpraxis Pirna, Pirna, Germany., Karaś P; KO-MED Centra Kliniczne Lublin, Lublin, Poland., Fitz-Patrick D; East West Medical Research Institute, Honolulu., Handelsman Y; Metabolic Institute of America, Tarzana., Warren M; Physicians East - Greenville, Endocrinology and Metabolism, Greenville., Hollander P; Baylor Endocrine Center, Dallas., Huffman D; University Diabetes & Endocrine Consultants, Chattanooga., Raskin P; Division of Endocrinology, University of Texas Southwestern Medical Center, Dallas., Oroszlán T; Zala County Hospital, Zalaegerszeg, Hungary., Lillestol M; Lillestol Research, Fargo., Ovalle F; Department of Medicine, University of Alabama at Birmingham, Birmingham.

المصدر: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Sep; Vol. 30 (9), pp. 810-816. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Comparative Study; Equivalence Trial

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9607439 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1530-891X (Print) Linking ISSN: 1530891X NLM ISO Abbreviation: Endocr Pract Subsets: MEDLINE

مواضيع طبية MeSH: Insulin Glargine*/therapeutic use , Insulin Glargine*/adverse effects , Diabetes Mellitus, Type 1*/drug therapy , Diabetes Mellitus, Type 1*/immunology , Diabetes Mellitus, Type 1*/blood , Biosimilar Pharmaceuticals*/therapeutic use , Biosimilar Pharmaceuticals*/adverse effects , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/adverse effects, Humans ; Male ; Female ; Adult ; Middle Aged ; Glycated Hemoglobin/analysis ; Insulin Antibodies/blood ; Insulin Antibodies/immunology ; Young Adult ; Treatment Outcome ; Adolescent ; Hypoglycemia/chemically induced ; Hypoglycemia/immunology

المؤلفون: Lee H; Samsung Bioepis, Co., Ltd, Incheon, Republic of Korea., Park J; Samsung Bioepis, Co., Ltd, Incheon, Republic of Korea., Jang H; Samsung Bioepis, Co., Ltd, Incheon, Republic of Korea., Lee SJ; AIMS BioScience, Seoul, Republic of Korea., Kim J; Samsung Medical Center, Seoul, Republic of Korea. jungryul.kim@samsung.com.

المصدر: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Sep; Vol. 80 (9), pp. 1325-1338. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/pharmacokinetics , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/pharmacology , Models, Biological* , Biosimilar Pharmaceuticals*/pharmacokinetics , Biosimilar Pharmaceuticals*/pharmacology, Humans ; Adult ; Male ; Female ; Middle Aged ; Young Adult ; Hemoglobinuria, Paroxysmal/drug therapy ; Adolescent ; Aged

المؤلفون: Feldman SR; Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina. Electronic address: sfeldman@wakehealth.edu., Narbutt J; Dermoklinika Centrum Medyczne s.c. M. Kierstan, J. Narbutt, A. Lesiak, Łódź, Poland., Girolomoni G; Division of Dermatology, Department of Medicine, University of Verona, Verona, Italy., Brzezicki J; Centrum Kliniczno-Badawcze J.Brzezicki, B.Górnikiewicz-Brzezicka, Lekarze Spółka Partnerska, Elbląg, Poland., Reznichenko N; Therapeutic Department, Military Hospital (Military Unit A3309) of Military Medical Clinical Center of Eastern Region, Zaporizhzhia, Ukraine., Zegadło-Mylik MA; ETG WARSZAWA, Warsaw, Poland., Pulka G; Centrum Medyczne All-med BADANIA KLINICZNE, Kraków, Poland., Dmowska-Stecewicz M; ETG Siedlce, Siedlce, Poland., Kłujszo E; Prywatny Gabinet Dermatologiczny Elżbieta Kłujszo, Kielce, Poland., Rekalov D; Medical Center of LLC 'Suchasna klinika', Zaporizhzhia, Ukraine., Rajzer L; L.Rajzer Specjalistyczny Gabinet Dermatologiczno-Kosmetyczny, Kraków, Poland., Lee J; Samsung Bioepis, Co. Ltd, Incheon, South Korea., Lee M; Samsung Bioepis, Co. Ltd, Incheon, South Korea., Rho YH; Samsung Bioepis, Co. Ltd, Incheon, South Korea.

المصدر: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep; Vol. 91 (3), pp. 440-447. Date of Electronic Publication: 2024 Apr 27.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Psoriasis*/drug therapy , Ustekinumab*/therapeutic use , Ustekinumab*/administration & dosage , Ustekinumab*/adverse effects , Biosimilar Pharmaceuticals*/therapeutic use , Biosimilar Pharmaceuticals*/adverse effects , Biosimilar Pharmaceuticals*/administration & dosage , Severity of Illness Index*, Humans ; Double-Blind Method ; Male ; Female ; Middle Aged ; Adult ; Dermatologic Agents/therapeutic use ; Dermatologic Agents/adverse effects ; Dermatologic Agents/administration & dosage ; Dermatologic Agents/pharmacokinetics ; Treatment Outcome ; Therapeutic Equivalency ; Injections, Subcutaneous

المؤلفون: Yao F; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China., Wang C; Taizhou Mabtech Pharmaceutical Co., Ltd, Taizhou, People's Republic of China., Ding J; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China., Zhang Q; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China., Zheng L; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China., Zhang Q; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China., Yang T; Taizhou Mabtech Pharmaceutical Co., Ltd, Taizhou, People's Republic of China., Zhang X; Taizhou Mabtech Pharmaceutical Co., Ltd, Taizhou, People's Republic of China., Shan Y; Taizhou Mabtech Pharmaceutical Co., Ltd, Taizhou, People's Republic of China., Hou S; Taizhou Mabtech Pharmaceutical Co., Ltd, Taizhou, People's Republic of China., Wang H; Taizhou Mabtech Pharmaceutical Co., Ltd, Taizhou, People's Republic of China., Zhou R; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China., Hu W; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.

المصدر: Drug design, development and therapy [Drug Des Devel Ther] 2024 Aug 29; Vol. 18, pp. 3891-3901. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).

نوع المنشور: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/pharmacokinetics , Antibodies, Monoclonal, Humanized*/adverse effects , Biosimilar Pharmaceuticals*/adverse effects , Biosimilar Pharmaceuticals*/pharmacokinetics , Healthy Volunteers*, Adult ; Humans ; Male ; Middle Aged ; Young Adult ; China ; Double-Blind Method ; East Asian People ; Therapeutic Equivalency

المؤلفون: Karkhaneh R; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Faghihi H; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Riazi-Esfahani H; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Abrishami M; Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Bazvand F; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Ebrahimiadib N; Department of Ophthalmology, Eye Research Center, Tehran University of Medical Sciences, Tehran, Iran., Johari M; Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Akhlaghi M; Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran., Shoeibi N; Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Norouzzadeh MH; Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Ansari Astaneh MR; Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Khojasteh H; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Imani Fooladi M; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Khodabande A; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Ghassemi F; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Khalili Pour E; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Zarei M; Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Mirshahi A; Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran., Fazel F; Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran., Ashraf H; Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Hosseini SM; Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Dourandeesh M; Eye Research Center, Department of Eye, Amiralmomenin Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran., Feghhi M; Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Alizadeh Y; Department of Ophthalmology, Eye Research Center, Guilan University of Medical Sciences, Rasht, Iran., Behboudi H; Eye Research Center, Department of Eye, Amiralmomenin Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran., Azadi P; Eye Research Center, Emam khomeini Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran., Sabzvari A; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran., Kafi H; Medical Department, Orchid Pharmed Company, Tehran, Iran., Ghasemi Falavarjani K; Eye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: drghasemi@yahoo.com.

المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2024 Aug; Vol. 8 (8), pp. 744-753. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III

بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Vascular Endothelial Growth Factor*/administration & dosage , Receptors, Vascular Endothelial Growth Factor*/antagonists & inhibitors , Recombinant Fusion Proteins*/administration & dosage , Recombinant Fusion Proteins*/adverse effects , Visual Acuity* , Intravitreal Injections* , Angiogenesis Inhibitors*/administration & dosage , Wet Macular Degeneration*/drug therapy , Wet Macular Degeneration*/diagnosis , Biosimilar Pharmaceuticals*/administration & dosage , Biosimilar Pharmaceuticals*/adverse effects , Biosimilar Pharmaceuticals*/therapeutic use, Humans ; Male ; Female ; Double-Blind Method ; Aged ; Treatment Outcome ; Tomography, Optical Coherence/methods ; Follow-Up Studies ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Dose-Response Relationship, Drug ; Aged, 80 and over ; Fluorescein Angiography/methods

المؤلفون: Shin SH; Department of Medicine, Yonsei University College of Medicine, Seoul, Korea., Kim JY; Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea., Kim SC; Department of Dermatology, Yongin Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Gyeonggi-do, Korea., Kim JH; Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.

المصدر: The Journal of dermatology [J Dermatol] 2024 Aug; Vol. 51 (8), pp. 1104-1107. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Rituximab*/adverse effects , Rituximab*/therapeutic use , Rituximab*/administration & dosage , Pemphigus*/drug therapy , Pemphigus*/immunology , Biosimilar Pharmaceuticals*/adverse effects , Biosimilar Pharmaceuticals*/therapeutic use , Biosimilar Pharmaceuticals*/administration & dosage , Biosimilar Pharmaceuticals*/economics, Humans ; Male ; Female ; Middle Aged ; Adult ; Treatment Outcome ; Aged ; Immunologic Factors/therapeutic use ; Immunologic Factors/adverse effects ; Immunologic Factors/administration & dosage ; Remission Induction/methods ; Retrospective Studies

المؤلفون: Oike T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Akizue N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: n.akizue@gmail.com., Ohta Y; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Koseki H; Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan., Saito M; Department of Gastroenterology, Chiba Medical Center, Chiba, Japan., Yokoyama Y; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Imai Y; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Taida T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Okimoto K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Saito K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Ogasawara S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan; Translational Research and Development Center, Chiba University Hospital, Chiba, Japan., Matsumura T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Nakagawa T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Arai M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan., Katsuno T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Fukuda Y; Department of Gastroenterology, Chiba Medical Center, Chiba, Japan., Kitsukawa Y; Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan., Kato J; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.

المصدر: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology [Arab J Gastroenterol] 2024 Aug; Vol. 25 (3), pp. 257-262. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Egypt NLM ID: 101298363 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2090-2387 (Electronic) Linking ISSN: 16871979 NLM ISO Abbreviation: Arab J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Crohn Disease*/drug therapy , Infliximab*/therapeutic use , Biosimilar Pharmaceuticals*/therapeutic use , Biosimilar Pharmaceuticals*/adverse effects , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/adverse effects, Humans ; Retrospective Studies ; Male ; Female ; Adult ; Treatment Outcome ; Remission Induction ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/adverse effects ; C-Reactive Protein/analysis ; C-Reactive Protein/metabolism ; Young Adult ; Middle Aged

المؤلفون: García-Miguel J; Servicio de Reumatología, Hospital Universitari Sagrat Cor de Barcelona, Barcelona, Spain., Yankova Komsalova L; Servicio de Reumatología, Hospital Marina Salud, Denia, Alicante, Spain., Mata Arnaiz C; Servicio de Reumatología, Hospital Comarcal de Laredo, Laredo, Cantabria, Spain., Alegre-Sancho JJ; Servicio de Reumatología, Hospital Universitario Dr. Peset, Valencia, Spain., González Polo J; Servicio de Reumatología, Hospital nuestra Señora del Prado, Talavera de la Reina, Spain., Torrente-Segarra V; Servei de Reumatologia, Consorci Sanitari Alt Penedès Garraf, Barcelona, Spain., Tornero Molina J; Servicio de Reumatología, Hospital Universitario de Guadalajara, Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá de Henares, Madrid, Spain., Navarro Angeles VA; Servicio de Reumatología, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain., Caramés C; Departamento Corporativo de Investigación e Innovación, Dirección Corporativa Asistencial y de Investigación, Quirónsalud, Madrid, Spain., Cristóbal I; Departamento Corporativo de Investigación e Innovación, Dirección Corporativa Asistencial y de Investigación, Quirónsalud, Madrid, Spain.

المصدر: Current medical research and opinion [Curr Med Res Opin] 2024 Aug; Vol. 40 (8), pp. 1431-1438. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE

مواضيع طبية MeSH: Adalimumab*/administration & dosage , Adalimumab*/therapeutic use , Adalimumab*/adverse effects , Arthritis, Rheumatoid*/drug therapy , Biosimilar Pharmaceuticals*/administration & dosage , Biosimilar Pharmaceuticals*/therapeutic use , Biosimilar Pharmaceuticals*/adverse effects , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/administration & dosage , Antirheumatic Agents*/adverse effects , Registries*, Humans ; Female ; Middle Aged ; Male ; Aged ; Spain ; Retrospective Studies ; Treatment Outcome ; Drug Substitution/statistics & numerical data ; Adult

المؤلفون: Kearsley-Fleet L; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Rokad A; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Tsoi MF; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Zhao SS; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Lunt M; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Watson KD; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Hyrich KL; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.

مؤلفون مشاركون: BSRBR-RA Contributors Group

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Aug 01; Vol. 63 (8), pp. 2082-2092.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Etanercept*/therapeutic use , Biosimilar Pharmaceuticals*/therapeutic use , Biosimilar Pharmaceuticals*/economics , Arthritis, Rheumatoid*/drug therapy , Antirheumatic Agents*/therapeutic use , Drug Substitution*, Humans ; Male ; Female ; Middle Aged ; Treatment Outcome ; Adult ; Proportional Hazards Models ; Aged ; Severity of Illness Index